Needham & Company
-
After-Hours Stock Movers 04/05: (PLCM) (PFE) (AMGN) Higher; (CREE) (LINE) (WYNN) Lower (more...)
-
Notable Analyst Rating Changes 10/01: (INVN) (HL) (TSN) Upgraded; (EBAY) (DF) (JNJ) Downgraded
-
CONMED (CNMD) Worth up to $59/Share in Takeover - Needham & Company
-
Pre-Open Stock Movers 4/15: (ONVO) (VSAR) (ZBRA) Higher; (LEDS) (PBY) (HGG) Lower (more...)
-
Notable Analyst Rating Changes 04/08: (FNFG) (FLEX) (JNPR) Upgraded; (GOOG) (JNJ) (MHR) Downgraded
-
Notable Analyst Rating Changes 02/07: (YNDX) MCP) (BBRY) Upgraded; (AKAM) (JNJ) (TQNT) Downgraded
-
StreetInsider.com Pre-Open Movers 01/22: (ATNI) (BOX) (RIMM) Higher; (ARNA) (NUS) (FTNT) Lower (more...)
-
Needham & Company maintains a 'Hold' on Perrigo Co. (PRGO); Q2 Outpaces Despite Some Segmental Head Winds
-
Needham & Company Reiterates a 'Buy' on Pharmacyclics (PCYC); 2012 Preview - PCI-32765 Transitioning to Phase 3
-
Needham & Company 2012 Biotech Preview
-
Needham & Company Maintains a 'Buy' on Hi Tech Pharmacal (HITK); Keeps The Approval Hitting Streak Alive With Another Infield Single
-
Needham & Company on Impax Labs (IPXL); Lawsuit Appears to Confirm That Generic Concerta Opportunity Remains A Real But Distant Star On Horizon
-
Needham & Company Reiterates a 'Buy' on Stereotaxis (STXS); New Capital Orders & Odyssey Expected To Drive Systems Growth in 2011
-
Needham & Company Downgrades Crucell N.V. (CRXL) to Hold; Reach an Agreement on Acquisition With J&J
-
Unusual 11 Mid-Day Movers 10/16: JOEZ, USEG, KNDI, TRGT Higher; CRYP, GNV, MTG, RDN Lower
-
Morning Movers 9/4: EXXI, LTXC, FNM, MTXX, FRE Higher; ARRY, ZQK, ELN Lower
-
Needham & Co Reiterates a 'Buy' on Given Imaging (GIVN); Could be Attractive Acquisition Target
-
Notable Analyst Rating Changes 8/15: SPWR, PCLN, ADSK Upgraded; JNJ, JWN, DNA Downgraded

